Recruiting studies: Pegfilgrastim

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of
Phase 4 · 3 location(s) · Ottawa Hospital Research Institute · NCT05753618 Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients
Phase 3 · 16 location(s) · The Affiliated People's Hospital of Ningbo University · NCT06520176 Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosi
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT01624805 An Open-label Prospective Study to Evaluate the Efficacy and Safety of Pegfilgrastim in Triple-Negative Breast Cancer Pa
NA · 2 location(s) · Yonsei University · NCT07525869 Correlation of Timing of Pegfilgrastim Administration and PIBP.
NA · 1 location(s) · Guangdong Provincial People's Hospital · NCT05841186

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.